No opioid peptide or morphine affected superoxide formation in human neutrophils or HL-60 cells under well-controlled conditions — resolving contradictory previous reports.
No effect under clean conditionsPrevious positive reports were likely methodological artifacts
What the researchers found
No opioid peptide or morphine, across a wide concentration range, affected superoxide formation in human neutrophils or HL-60 cells under defined experimental conditions.
Why it matters
This resolved conflicting reports by showing that previous positive findings may have been due to experimental artifacts. Opioids do not directly affect this immune cell function.
How the study worked
Human neutrophils and HL-60 cells were exposed to various opioids and immune activators. Superoxide production was measured by standard assays under carefully defined conditions.
What this study cannot tell us
In-vitro study that only measured one immune function (superoxide production). Opioids may affect other aspects of immune cell behavior not tested here.
How to read the evidence
Moderate — well-controlled negative study resolving contradictory literature.
When this study was published
Published in 1989 — important methodological correction for the field.
The bigger picture
Important negative results prevent misdirected research. This study showed opioid peptides do not directly affect this specific immune function, despite claims in the literature.
Questions still open
- Were previous positive results due to contamination or assay conditions?
- Do opioids affect other immune cell functions instead?
Common questions
Why are negative results important?
Do opioids affect immunity at all?
Read the original research
Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells.
Naunyn-Schmiedeberg's archives of pharmacology, 340(1), 101-6
Citation
Seifert, R; Burde, R; Schultz, G. (1989). Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells.. Naunyn-Schmiedeberg's archives of pharmacology, 340(1), 101-6.